AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6722830
Drug: 3 X
RxNorm normalized name: Xenon (133 xe)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 X 10(6) units of partially purified human leukocyte (alpha) interferon by daily im injection for 42 days
Trial: 6722830
Drug: 9 X
RxNorm normalized name: TachoSil 1.9 X 1.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9 X 10(6) units of partially purified human leukocyte (alpha) interferon by daily im injection for 42 days
Trial: 27737636
Drug: Lubiprostone (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lubiprostone (24 mcg) + 2 L PEG (GrB)
Trial: 27737636
Drug: Placebo +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo + 2 L PEG (GrA)
Trial: 27737636
Drug: Lubiprostone (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lubiprostone (24 mcg) + 1.5 L PEG (GrC)
Trial: 27737636
Drug: Lubiprostone (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lubiprostone (24 mcg) + 1 L PEG (GrD)
Trial: 12442956
Drug: Heliox-driven bronchodilator
RxNorm normalized name: Helixate
DrugBank: Antihemophilic factor, human recombinant (DB00025)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heliox-driven bronchodilator (HDBD)
Trial: 12442956
Drug: Air-driven bronchodilator
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Air-driven bronchodilator (ADBD)
Trial: 9809623
Drug: Pentoxifylline and
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline and ciprofloxacin (PC) therapy for 12 weeks
Trial: 9809623
Drug: Pentoxifylline and
RxNorm normalized name: Pentoxifylline
DrugBank: Pentoxifylline (DB00806)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pentoxifylline and ciprofloxacin with dexamethasone (PCD) therapy
Trial: 9809623
Drug: PC therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PC therapy
Trial: 1974688
Drug: Formoterol MDI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formoterol MDI (2 X 12 micrograms) during 3-month monotherapy
Trial: 14658
Drug: Diazepam (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (10 mg and 20 mg)
Trial: 7083724
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (15 mg) in supine position (part A)
Trial: 7083724
Drug: Evening dose
RxNorm normalized name: Jornay PM, (evening dose) 60 mg/24 hr oral capsule, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evening dose of midazolam (part C)
Trial: 7083724
Drug: Morning dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morning dose of midazolam (part B)
Trial: 18343245
Drug: Fluvastatin XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin XL 80 mg/d + Ezetimibe 10 mg/d
Trial: 18343245
Drug: Fluvastatin XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin XL 80 mg/d
Trial: 12784090
Drug: Testosterone 50
RxNorm normalized name: testosterone 50 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone 50 mg monthly injections
Trial: 12784090
Drug: Oxandrolone at
RxNorm normalized name: Oxandrolone
DrugBank: Oxandrolone (DB00621)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxandrolone at a weekly dose of 0.7 mg/kg
Trial: 12784090
Drug: Testosterone 25
RxNorm normalized name: testosterone 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone 25 mg monthly injections
Trial: 10573656
Drug: BCG high
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG high dose (0.1 mg/0.1 ml)
Trial: 10573656
Drug: BCG low
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG low dose (0.01 mg/0.1 ml)
Trial: 8824687
Drug: Tramadol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (100 mg orally)
Trial: 8824687
Drug: Yohimbine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine (0.1 mg kg‐1 intravenously)
Trial: 8824687
Drug: Yohimbine +
RxNorm normalized name: YOHIMBINE
DrugBank: Yohimbine (DB01392)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yohimbine + Naloxone (0.8 mg intravenously)
Trial: 2061684
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol and estriol (2:1 ratio), 4 mg/day for 21 days (Group A)
Trial: 2061684
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol and estriol (2:1 ratio), 4 mg/day for 28 days (Group B)
Trial: 2061684
Drug: Oral estradiol
RxNorm normalized name: estradiol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral estradiol and estriol (2:1 ratio), 4 mg/day for 35 days (Group C)
Trial: 6340274
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical management (intravenous methylprednisolone)
Trial: 25208590
Drug: Aspirin intake
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin intake at bedtime (80 mg)
Trial: 25208590
Drug: Aspirin intake
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin intake on awakening (80 mg)
Trial: 17823506
Drug: Pyridoxamine 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridoxamine 50 mg twice daily in PYR-206; escalated to 250 mg twice daily in PYR-205/207
Trial: 17823506
Drug: Pyridoxamine 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridoxamine 250 mg twice daily in PYR-205/207
Trial: 7042559
Drug: Imipramine pamoate
RxNorm normalized name: Imipramine Pamoate
DrugBank: Imipramine (DB00458)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Imipramine pamoate (single dose of 150 mg)
Trial: 7042559
Drug: Imipramine hydrochloride
RxNorm normalized name: Imipramine Hydrochloride
DrugBank: Imipramine (DB00458)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Imipramine hydrochloride (divided dose of 150 mg)
Trial: 21938072
Drug: Mannooligosaccharides (MOS)
RxNorm normalized name: fructooligosaccharide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mannooligosaccharides (MOS) 4 g/day
Trial: 10343192
Drug: Intraperitoneal carboplatin
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraperitoneal carboplatin (CBP) 350 mg/m2 plus intravenous cyclophosphamide (CTX) 600 mg/m2
Trial: 10343192
Drug: Intravenous carboplatin
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous carboplatin (CBP) 350 mg/m2 plus intravenous cyclophosphamide (CTX) 600 mg/m2
Trial: 7548495
Drug: Ciprofloxacin 250
RxNorm normalized name: ciprofloxacin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 250 mg single dose
Trial: 1900983
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of green coffee extract
Trial: 1900983
Drug: Disodium cromoglycate
RxNorm normalized name: Disodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disodium cromoglycate (DSCG) pretreatment (80 mg)
Trial: 31861026
Drug: Valsartan-amlodipine single-pill
RxNorm normalized name: valsartan, amlodipine and hydrochlorothiazide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan-amlodipine single-pill combination (SPC)
Trial: 31861026
Drug: Valsartan and
RxNorm normalized name: valsartan and aliskiren
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan and amlodipine combination (Control)
Trial: 28891056
Drug: Remifentanil target-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil target-controlled infusion using the Minto model
Trial: 25735200
Drug: Trauma-informed integrative
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trauma-informed integrative treatment for PTSD/SUD
Trial: 19376304
Drug: Warfarin (INR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (INR 2-3)
Trial: 11336370
Drug: Intra-articular ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular ropivacaine injection (20 ml of ropivacaine 0.5%)
Trial: 11336370
Drug: Intra-articular ropivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular ropivacaine injection
Trial: 9138046
Drug: 12-week group
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-week group cognitive-behavioral therapy (CBT)
Trial: 9138046
Drug: Extended cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended cognitive-behavioral therapy (CBT)
Trial: 25987796
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Alequel™, an autologous protein‐containing colon extract, 3 doses per week for 15 weeks (total of 45 doses)
Trial: 25987796
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of Alequel™, an autologous protein‐containing colon extract
Trial: 25411597
Drug: Ipragliflozin 12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipragliflozin 12.5 mg
Trial: 23163880
Drug: Ipragliflozin 150
RxNorm normalized name: canagliflozin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ipragliflozin 150 mg
Trial: 10875716
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg ondansetron and 1.25 mg droperidol combination
Trial: 1355599
Drug: Neostigmine (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine (administered after vecuronium or atracurium)
Trial: 6339331
Drug: Doxycycline (single-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (single-dose prophylactic antibiotic)
Trial: 30597114
Drug: Self-medication with
RxNorm normalized name: chloroxylenol Medicated Pad [E-Z Scrub with Ultradex]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-medication with antimicrobials
Trial: 30597114
Drug: Self-medication with
RxNorm normalized name: chloroxylenol Medicated Pad [E-Z Scrub with Ultradex]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-medication with antihypertensives or antihyperglycemics
Trial: 30597114
Drug: Self-treatment with
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-treatment with antimicrobials
Trial: 19013761
Drug: Drug therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug therapies in RCTs
Trial: 12213870
Drug: Lanreotide (LAN)
DrugBank: Lanreotide (DB06791)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lanreotide (LAN) 60 mg/month (n = 11)
Trial: 10233220
Drug: Urea-containing moisturizer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urea-containing moisturizer applied twice daily for 20 days
Trial: 2379229
Drug: Clindamycin 150
RxNorm normalized name: clindamycin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin 150 mg orally four times daily for seven days
Trial: 2379229
Drug: Ampicillin 250
RxNorm normalized name: ampicillin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ampicillin 250 mg orally four times daily for seven days
Trial: 78297
Drug: Salbutamol inhalers
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol inhalers used 30 min before inhalation of 100 microgram of beclomethasone dipropionate (B.D.P.)
Trial: 25399552
Drug: Dacarbazine (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dacarbazine (1000 mg/m² every 3 weeks)
Trial: 16954710
Drug: Topical 2%
RxNorm normalized name: menthol topical 2% topical gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical 2% lidocaine gel
Trial: 16954710
Drug: Artificial tear
RxNorm normalized name: Artificial Tears
DrugBank: Polyethylene glycol 400 (DB11077)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Artificial tear gel
Trial: 29442086
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg of ibuprofen orally 1 h before the endodontic procedure (Group A)
Trial: 29442086
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ibuprofen and low-level laser therapy (Group C)
Trial: 29442086
Drug: No preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No preoperative ibuprofen nor low-level laser irradiation (Group D)
Trial: 24012063
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral and enema mesalazine (4 g/day oral + 1 g enema)
Trial: 24012063
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral and enema mesalazine
Trial: 24012063
Drug: Oral mesalazine
RxNorm normalized name: mesalamine Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral mesalazine (4 g/day)
Trial: 22311905
Drug: Immediate-release aspirin
RxNorm normalized name: aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Immediate-release aspirin
Trial: 18715213
Drug: Insulin guidance
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin guidance software (ACCU‐CHEK Advisor)
Trial: 15761191
Drug: Torcetrapib (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torcetrapib (120 mg QD)
Trial: 15761191
Drug: Torcetrapib (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Torcetrapib (120 mg BID)
Trial: 12454555
Drug: Venlafaxine XR
RxNorm normalized name: venlafaxine Extended Release Oral Capsule
DrugBank: Venlafaxine (DB00285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venlafaxine XR (75 to 225 mg/day)
Trial: 12454555
Drug: Venlafaxine XR
RxNorm normalized name: venlafaxine Extended Release Oral Capsule
DrugBank: Venlafaxine (DB00285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Venlafaxine XR (37.5 mg, 75 mg, or 150 mg, fixed-dose)
Trial: 1673944
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate 10 mg BID
Trial: 1673944
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (medroxyprogesterone acetate and conjugated estrogens)
Trial: 6108592
Drug: Nabilone (comparatively
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabilone (comparatively lower doses)
Trial: 28911510
Drug: Lower epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lower epinephrine dosage
Trial: 19584831
Drug: PEG‐IFN alpha‐2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG‐IFN alpha‐2b and lamivudine (100 mg/day)
Trial: 17426158
Drug: Sulfadoxine-pyrimethamine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine-pyrimethamine (25 mg/kg of the sulfadoxine component)
Trial: 14692469
Drug: zaleplon 10
RxNorm normalized name: zaleplon 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: zaleplon 10 mg
Trial: 14692469
Drug: temazepam 15
RxNorm normalized name: temazepam 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: temazepam 15 mg
Trial: 15198277
Drug: time‐released melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: time‐released melatonin 6 mg
Trial: 11351356
Drug: Pycnogenol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pycnogenol (50 mg x 3/day for 2 months)
Trial: 9437195
Drug: Alpha-tocopherol and
RxNorm normalized name: Alpha-tocopherol and selenium only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-tocopherol and beta-carotene (50 mg and 20 mg daily respectively)
Trial: 3287167
Drug: Colchicine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colchicine (1 mg per day, five days per week)
Trial: 27330807
Drug: CVac maintenance
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CVac maintenance treatment (10 doses over 56 weeks)
Trial: 18300236
Drug: Sorafenib 200
RxNorm normalized name: sorafenib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib 200 mg orally twice daily and bevacizumab 5 mg/kg to 10 mg/kg intravenously every 2 weeks for 28-day cycles
Trial: 12796772
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (4 x 10(9) particle units)
Trial: 12796772
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (4 x 10(10) particle units)
Trial: 8866624
Drug: Mepyramine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mepyramine (0.5 mg.kg‐1) pretreatment
Trial: 1346499
Drug: Oral cyclophosphamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cyclophosphamide or dapsone therapy (as second-line treatment)
Trial: 6376164
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg curantyl
Trial: 6376164
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg no-spa
Trial: 31109200
Drug: Methylphenidate (36
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (36 or 54 mg/day of extended-release)
Trial: 28739058
Drug: Acupressure bead
RxNorm normalized name: Bead Tree Leaf
DrugBank: Azadirachta indica leaf (DB14352)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupressure bead patch (N=57)
Trial: 28739058
Drug: Sham acupressure
RxNorm normalized name: ACUPRESSURE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham acupressure patch (N=53)
Trial: 25643863
Drug: 10 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 µg Engerix-B
Trial: 25643863
Drug: 20 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 µg Engerix-B
Trial: 24094079
Drug: Double-dose statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-dose statin
Trial: 9786811
Drug: Radioiodine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioiodine therapy alone
Trial: 9786811
Drug: Radioiodine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radioiodine plus prednisone (3-month course, initial dosage 0.4 to 0.5 mg/kg/day)
Trial: 9786811
Drug: High-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose oral prednisone (80 to 100 mg/d for 6 months) and orbital radiation therapy (20 Gy per eye over 2 weeks)
Trial: 3146774
Drug: Ritanserin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ritanserin (10 mg o.d. in the morning)
Trial: 14738167
Drug: Tablet form
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet form of misoprostol (400 microg)
Trial: 14738167
Drug: Capsule form
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capsule form of misoprostol (400 microg)
Trial: 9339095
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg of dinoprostone
Trial: 7692109
Drug: Single-dose ceftriaxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose ceftriaxone (2 gm.)
Trial: 7692109
Drug: Trimethoprim-sulfamethoxazole (160/800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimethoprim-sulfamethoxazole (160/800 mg.)
Trial: 23214304
Drug: Carepolis gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carepolis gel with propolis content (CT)
Trial: 23214304
Drug: Dental Polis
RxNorm normalized name: dental polish-varnishes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dental Polis DX toothpaste without propolis content (G)
Trial: 23214304
Drug: Carepolis gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carepolis gel without propolis content (CG)
Trial: 20015704
Drug: Topical capsaicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical capsaicin cream (0.075%) applied to the C(5) dermatome
Trial: 20015704
Drug: Topical placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical placebo cream applied to the C(5) dermatome
Trial: 15938534
Drug: Fosinopril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fosinopril (10 mg daily, increased to 20 mg)
Trial: 15938534
Drug: Metoprolol (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (25 mg twice a day, increased to 75 mg)
Trial: 7500456
Drug: Mitomycin C
RxNorm normalized name: Mitomycin C
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin C and BCG (alternating therapy)
Trial: 2310248
Drug: Verapamil (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (0.1 mg/kg up to 10 mg) intravenously three to five minutes before aortic cross‐clamping
Trial: 382148
Drug: 10 mg,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg, 20 mg, or 50 mg of domperidone orally
Trial: 382148
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg domperidone intravenously
Trial: 30641712
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 (50000 IU) supplement weekly
Trial: 19149522
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg once-daily
Trial: 19149522
Drug: Duloxetine 60
RxNorm normalized name: duloxetine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 60 mg twice-daily